CLPT vs. DCTH
CLPT (ClearPoint Neuro, Inc.) and DCTH (Delcath Systems, Inc.) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 5 years, CLPT returned -2.37%/yr vs 1.05%/yr for DCTH. At a 0.30 correlation, their price movements are largely independent.
Performance
CLPT vs. DCTH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLPT achieves a 31.43% return, which is significantly higher than DCTH's 21.19% return.
CLPT
- 1D
- -2.97%
- 1M
- 57.17%
- YTD
- 31.43%
- 6M
- 24.09%
- 1Y
- 54.60%
- 3Y*
- 39.95%
- 5Y*
- -2.37%
- 10Y*
- —
DCTH
- 1D
- -0.41%
- 1M
- 11.07%
- YTD
- 21.19%
- 6M
- 18.60%
- 1Y
- -11.75%
- 3Y*
- 30.01%
- 5Y*
- 1.05%
- 10Y*
- —
CLPT vs. DCTH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
CLPT ClearPoint Neuro, Inc. | 31.43% | -11.05% | 126.51% | -19.83% | -24.51% | -29.39% | 200.95% |
DCTH Delcath Systems, Inc. | 21.19% | -16.11% | 189.42% | 15.56% | -53.55% | -56.75% | 98.23% |
Correlation
The correlation between CLPT and DCTH is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.37 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Feb 12, 2020 | 0.30 |
The correlation between CLPT and DCTH shifts across timeframes, from 0.29 (5 years) to 0.44 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
CLPT:
$531.25M
DCTH:
$440.90M
CLPT:
-$1.01
DCTH:
$0.01
CLPT:
12.68
DCTH:
7.14
CLPT:
28.20
DCTH:
3.91
CLPT:
$40.61M
DCTH:
$65.45M
CLPT:
$25.32M
DCTH:
$77.75M
CLPT:
-$25.05M
DCTH:
$222.00K
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLPT vs. DCTH — Risk / Return Rank
CLPT
DCTH
CLPT vs. DCTH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ClearPoint Neuro, Inc. (CLPT) and Delcath Systems, Inc. (DCTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLPT | DCTH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.76 | ||
| Sortino ratioReturn per unit of downside risk | +1.64 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.00 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 0.78 | -0.28 | +1.06 |
| Martin ratioReturn relative to average drawdown | 1.20 | -0.45 | +1.64 |
Loading charts...
Drawdowns
CLPT vs. DCTH - Drawdown Comparison
The maximum CLPT drawdown since its inception was -84.62%, smaller than the maximum DCTH drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for CLPT and DCTH.
Loading charts...
Drawdown Indicators
| CLPT | DCTH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.62% | -99.96% | +15.34% |
Max Drawdown (1Y)Largest decline over 1 year | -70.74% | -41.71% | -29.03% |
Max Drawdown (3Y)Largest decline over 3 years | -70.74% | -62.87% | -7.87% |
Max Drawdown (5Y)Largest decline over 5 years | -79.96% | -82.21% | +2.25% |
Current DrawdownCurrent decline from peak | -39.26% | -99.80% | +60.54% |
Average DrawdownAverage peak-to-trough decline | -53.48% | -96.43% | +42.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 45.76% | 26.35% | +19.41% |
Volatility
CLPT vs. DCTH - Volatility Comparison
ClearPoint Neuro, Inc. (CLPT) has a higher volatility of 30.44% compared to Delcath Systems, Inc. (DCTH) at 14.06%. This indicates that CLPT's price experiences larger fluctuations and is considered to be riskier than DCTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLPT | DCTH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.44% | 14.06% | +16.38% |
Volatility (6M)Calculated over the trailing 6-month period | 66.14% | 33.19% | +32.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 104.43% | 49.82% | +54.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.88% | 72.98% | +5.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.80% | 109.83% | -29.03% |
Dividends
CLPT vs. DCTH - Dividend Comparison
Neither CLPT nor DCTH has paid dividends to shareholders.
Financials
CLPT vs. DCTH - Financials Comparison
This section allows you to compare key financial metrics between ClearPoint Neuro, Inc. and Delcath Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CLPT and DCTH have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLPT has higher volatility (30.44%) compared to DCTH (14.06%). In terms of maximum drawdown, CLPT dropped -84.62% vs DCTH's -99.96%.
CLPT currently has the higher Sharpe Ratio (0.53 vs -0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLPT and DCTH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer